Alchemi - Sugarland

Clinical research site in Sugar Land, Texas · 13515 SOUTHWEST FWY, SUGAR LAND, TX 77478-3562 · (281) 240-5095

As of July 2026, 1 paid clinical trial is recruiting at Alchemi - Sugarland in Sugar Land, Texas. Active studies at this site focus on Central Line Associated Blood Stream Infections (CLABSI) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Alchemi - Sugarland (1)

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

for Central Line Associated Blood Stream Infections (CLABSI)

16 locations incl. Los Angeles

Sponsor: CorMedix

Sex: All·Age: 18+

Code: NCT06822426·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

More research sites in Sugar Land

Houston Methodist Sugar Land Hospital (15 trials)
MD Anderson in Sugar Land (15 trials)
UT MD Anderson - Sugar Land (11 trials)
Texas Oncology - Gulf Coast (7 trials)
Berkeley Eye Center (5 trials)
The University of Texas, MD Anderson Cancer Center - Sugar Land (5 trials)
Alkermes Investigational Site (4 trials)
Siena Research Network (4 trials)
Complete Dermatology (3 trials)
Complete Dermatology - Sugar Land (3 trials)

Explore more

Paid clinical trials in Sugar Land, TX · Texas clinical trials